Diabetes

Type 2 Diabetes Type 1 Diabetes Prediabetes Diabetes Management Medications Management Treatment Options Complications Treatment Blood Sugar Control

Novo Nordisk Expands Aspect Partnership, Transfers Diabetes Cell Tech as Aspect Takes Lead

The revamp shifts development to a Canada-based platform led by Aspect with Novo switching to a funding role and keeping economic rights.

Slime-Mold Enzyme Unlocks High-Yield Production of Low-Calorie Sugar Tagatose

Breath-Based Glucose Pendant Debuts at CES as PreEvnt Seeks FDA Review

Daylight Exposure Improves Glucose Stability in Controlled Type 2 Diabetes Trial

Abbott Launches Libre Assist in FreeStyle Libre App to Predict Meal Glucose Impact

U.S. Gestational Diabetes Climbed 36% Since 2016, New National Study Shows

Cipla Launches Afrezza, India’s First Commercial Inhaled Insulin

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Brazil Cracks Down on Illicit Mounjaro Sales as Lilly Launches QR Verification Tool

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

Bringing Blood Sugar to Normal in Prediabetes Halves Major Heart Risks, Study Finds

MIT’s Light-Based Glucose Monitor Matches CGMs in Early Test as Wearable Trials Begin

French Woman Buried Alive After Diabetic Coma on First Date in Morocco, Coroners Find

Pakistan Tops World in Diabetes Prevalence, IDF Atlas 2025 Finds

WHO Backs GLP-1 Weight-Loss Drugs as New Data Highlight Limits and Unknowns

Study Finds Early T1D CD4 T-Cell Signature in Pancreatic Lymph Nodes

Eli Lilly Hits $1 Trillion Valuation on GLP‑1 Weight‑Loss Boom

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Brain Maps of GLP-1 Drugs Point to Paths for Weight Loss Without Nausea

Brain Implants Show Mounjaro Temporarily Quiets Food-Craving Brain Signal